CFO and Treasurer of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Drapkin Kimberlee C, sells 3,130 shares worth $21,910
According to Jounce Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:19 AM, company CFO and Treasurer, Drapkin Kimberlee C disclosed selling 3,130 shares at a cost of $7.00. At the time of this transaction (Jan 08), this trade was worth $21,910 in total. As of Jan 08, Drapkin Kimberlee C now owns 55,881 shares in total worth about $408,490.11.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) CFO and Treasurer, Drapkin Kimberlee C, we have the following information:
- SEC Form 4 filing: Jan 07: Sold 2,697 shares at the rate of $6.76 per share. Total worth of this trade was $18,232. Total number of shares owned as of Jan 07 were 59,011
- SEC Form 4 filing: Sep 01: Sold 7,200 shares at the rate of $8.06 per share. Total worth of this trade was $58,032. Total number of shares owned as of Sep 01 were 61,708
- SEC Form 4 filing: Aug 14: Sold 984 shares at the rate of $4.64 per share. Total worth of this trade was $4,566. Total number of shares owned as of Aug 14 were 70,106
Posted by
George Daniels
on Monday January 11 2021, 9:44 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
